Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Neuphoria Therapeutics (NASDAQ:NEUP) through any online brokerage.
Other companies in Neuphoria Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Neuphoria Therapeutics has a consensus price target of $35.00.
The stock price for Neuphoria Therapeutics (NASDAQ: NEUP) is $3.7 last updated September 18, 2026 at 4:01 PM EDT.
There are no upcoming dividends for Neuphoria Therapeutics.
Neuphoria Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Neuphoria Therapeutics.
Neuphoria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.